Zhou, Xiaofei
Vaishampayan, Ulka
Mahalingam, Devalingam
Harvey, R. Donald
Chung, Ki Young
Sedarati, Farhad
Dong, Cassie
Faller, Douglas V.
Venkatakrishnan, Karthik
Gupta, Neeraj
Article History
Received: 6 May 2022
Accepted: 11 July 2022
First Online: 6 August 2022
Declarations
:
: This study was conducted in compliance with the independent ethics committee (IEC) requirements of the participating region, informed consent regulations, and applicable regulatory requirements (including International Council for Harmonization [ICH] guidelines), in accordance with ethical principles founded in the Declaration of Helsinki.
: Informed consent was obtained from all individual participants included in the study.
: XZ is employed by Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA. UV has received honoraria from Sanofi, Exelixis, Pfizer, Bayer; consulting fees from BMS, Merck, Exelixis, Bayer, Aveo; and grants/funds from Merck. DM has received honoraria from Amgen, BMS, Exelixis, Eisai; consulting fees from Qurient, OncoOne; and grants/funds from Amgen, Merck, Oncolytics. RDH has received research funding to their institution that supports their salary from: Abbisko, AbbVie, Actuate, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Boston Biomedical, Genmab, GlaxoSmithKline, Infinity, InhibRx, Janssen, Merck, Mersana, Meryx, Nektar, Novartis, Pfizer, Regeneron, Sanofi, Sutro, Takeda, Turning Point Therapeutics, Xencor; and reports consultancy for: Amgen, GlaxoSmithKline. KYC has nothing to disclose. FS is employed by Takeda. CD is employed by Takeda; and has ownership of stock/shares in Takeda and Settle Genetics. DVF is employed by Takeda; has ownership of stock/shares in Viracta Therapeutics, Briacell Therapeutics, Phoenicia Biosciences, R2ccouncil, LLC; was on the advisory council/committee for Viracta Therapeutics, Briacell Therapeutics; and owns multiple patents unrelated to this work. KV is a previous employee of Takeda; and a current employee of EMD Serono Research & Development Institute, Inc., Billerica, MA. NG is employed by Takeda; and has ownership of stock/shares in Takeda.